Qilu Pharmaceutical Co., Ltd.

Qilu Pharmaceutical consistently focuses on revolutionary development strategies guided by market demand and product innovation. Qilu has established extensive cooperation with domestic and international partners on multiple R&D projects. Devoted to the cultivation of talent, Qilu has invested in a highly qualified R&D team and efficient R&D capabilities. The 100+new drugs successfully developed by Qilu constitutes as a large part of future production and sales for Qilu Pharmaceutical and partners. A number of technological achievements have garnered national and provincial scientific and technological progress awards for Qilu.

Qilu Pharmaceutical currently has nine manufacturing sites for finished dosage forms, chemical synthesis, genetic-engineering, fermentation and other products. These modern production sites incorporate automated production lines while utilizing key equipment and analytical instruments from leading suppliers all over the world. As a result, Qilu has been one of the leading global suppliers with substantial manufacturing capacity for top quality antibiotic and oncology products.